Kiniksa Pharmaceuticals International Plc (KNSA)
39.41
+1.49
(+3.93%)
USD |
NASDAQ |
Jan 16, 16:00
39.44
+0.04
(+0.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Shareholders Equity (Annual): 438.44M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Marker Therapeutics, Inc. | 18.56M |
| NovoCure Ltd. | 360.18M |
| LivaNova Plc | 1.320B |
| ADMA Biologics, Inc. | 349.02M |
| Akanda Corp. | 4.276M |